Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran

This study highlights the substantial impact of COVID-19 vaccination in reducing infection, hospitalization, and mortality rates in Iran. The results support the use of whole-virus and vector-based vaccines as more effective options for preventing COVID-19 outcomes. The study also emphasizes the importance of considering various factors, including medical history and side effects, when evaluating the effectiveness of different vaccine types. The findings of this study can inform public health policy and vaccination strategies in Iran and other countries.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2025-01-09
DOI
https://doi.org/10.1186/s12879-025-10449-w
Citations
2
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran

Mohammad Taghi Shakeri, Seyed Saeed Tabatabaee, Rasoul Raesi, Vahid Ghavami et al.
2 citations
BMC Infectious Diseases
SARS-CoV-2 and COVID-19 Research
2.79
article

Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran

Mohammad Taghi Shakeri, Seyed Saeed Tabatabaee, Rasoul Raesi, Vahid Ghavami, Davoud Tanbakuchi, Ehsan Mosa Farkhani, Nadiasadat Taghavi Razavizadeh, Maryam Salari
article en
2 citations

Abstract

This study highlights the substantial impact of COVID-19 vaccination in reducing infection, hospitalization, and mortality rates in Iran. The results support the use of whole-virus and vector-based vaccines as more effective options for preventing COVID-19 outcomes. The study also emphasizes the importance of considering various factors, including medical history and side effects, when evaluating the effectiveness of different vaccine types. The findings of this study can inform public health policy and vaccination strategies in Iran and other countries.

BMC Infectious DiseasesVol. 25(1)
Mashhad University of Medical Sciences (IR), Torbat Heydarieh University of Medical Sciences (IR)
Mashhad University of Medical Sciences, Vice Chancellor for Research and Technology, Kerman University of Medical Sciences
Good health and well-being
Openalex Percentile: Top 13%
SARS-CoV-2 and COVID-19 Research
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Investigating the effectiveness of whole-virus, protein-based, and vector-based SARS-CoV-2 vaccines on the rates of COVID-19 infection, hospitalization, and mortality: a historical cohort study in Iran — Mohammad Taghi Shakeri, Seyed Saeed Tabatabaee, et al. · BMC Infectious Diseases (2025) | TGRS Research Map | TGRS